Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald F Brophy

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Proteomics|December 16, 2014
Intact stable isotope labeled plasma proteins from the SILAC-labeled HepG2 secretomeJohn B Mangrum, Erika J Martin, Donald F Brophy, et al.
Resuscitation|October 27, 2009
Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitationNathan J White, Erika J Martin, Donald F Brophy, et al.
The Annals of Pharmacotherapy|March 29, 2013
Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic eventsGretchen M Brophy, Christina L Candeloro, Jaime R Robles, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation timeDonald F Brophy, Erika J Martin, Todd W B Gehr, et al.
The Annals of Pharmacotherapy|September 29, 2005
Darbepoetin alfa therapeutic interchange protocol for anemia in dialysisDonald F Brophy, Elizabeth Bd Ripley, Denise R Kockler, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 21, 2015
Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleedingStacy A Voils, Erika J Martin, Bassem M Mohammed, et al.
Thrombosis Research|June 24, 2006
The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patientsDonald F Brophy, Erika J Martin, Sheryl L Carr, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 2010
Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acidsBrian L Henry, Jay N Thakkar, Erika J Martin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2021
An in vitro pharmacodynamic spiking study of befovacimab, a tissue factor pathway inhibitor monoclonal antibody, in blood samples from patients with severe FVIII deficiencyErika J Martin, Melinda E Nolte, Janice Kuhn, et al.
Journal of Clinical Pharmacology|July 21, 2006
The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapiesDonald F Brophy, Marcus E Carr, Erika J Martin, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Proteomics|December 16, 2014
Intact stable isotope labeled plasma proteins from the SILAC-labeled HepG2 secretomeJohn B Mangrum, Erika J Martin, Donald F Brophy, et al.
Resuscitation|October 27, 2009
Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitationNathan J White, Erika J Martin, Donald F Brophy, et al.
The Annals of Pharmacotherapy|March 29, 2013
Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic eventsGretchen M Brophy, Christina L Candeloro, Jaime R Robles, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation timeDonald F Brophy, Erika J Martin, Todd W B Gehr, et al.
The Annals of Pharmacotherapy|September 29, 2005
Darbepoetin alfa therapeutic interchange protocol for anemia in dialysisDonald F Brophy, Elizabeth Bd Ripley, Denise R Kockler, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 21, 2015
Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleedingStacy A Voils, Erika J Martin, Bassem M Mohammed, et al.
Thrombosis Research|June 24, 2006
The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patientsDonald F Brophy, Erika J Martin, Sheryl L Carr, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 2010
Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acidsBrian L Henry, Jay N Thakkar, Erika J Martin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2021
An in vitro pharmacodynamic spiking study of befovacimab, a tissue factor pathway inhibitor monoclonal antibody, in blood samples from patients with severe FVIII deficiencyErika J Martin, Melinda E Nolte, Janice Kuhn, et al.
Journal of Clinical Pharmacology|July 21, 2006
The pharmacokinetics of enoxaparin do not correlate with its pharmacodynamic effect in patients receiving dialysis therapiesDonald F Brophy, Marcus E Carr, Erika J Martin, et al.
Pageof 6